Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38953 | 0.82 | SMN1; SMN2 (0.56) | SMN1; SMN2ALDH1A1MAPK1 | |
| Iodide SCHEMBL11830139 | 0.79 | SMN1; SMN2 (0.54) | SMN1; SMN2ALDH1A1MAPK1 | |
| Water SCHEMBL4837114 | 0.79 | SMN1; SMN2 (0.54) | SMN1; SMN2ALDH1A1MAPK1 | |
| SCHEMBL10892597 | 0.79 | SMN1; SMN2 (0.54) | SMN1; SMN2ALDH1A1MAPK1 | |
| Ammonia Solution, Strong SCHEMBL27484151 | 0.79 | SMN1; SMN2 (0.54) | SMN1; SMN2ALDH1A1MAPK1 | |
| SCHEMBL29829697 | 0.79 | SMN1; SMN2 (0.54) | SMN1; SMN2ALDH1A1MAPK1 | |
| Hydrochloric Acid SCHEMBL5218604 | 0.79 | SMN1; SMN2 (0.54) | SMN1; SMN2ALDH1A1MAPK1 | |
| Water SCHEMBL7733637 | 0.79 | SMN1; SMN2 (0.54) | SMN1; SMN2ALDH1A1MAPK1 | |
| Hydrochloric Acid SCHEMBL20704047 | 0.79 | SMN1; SMN2 (0.54) | SMN1; SMN2ALDH1A1MAPK1 | |
| Ethylene SCHEMBL6311271 | 0.77 | SMN1; SMN2 (0.52) | SMN1; SMN2ALDH1A1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9676686-B2 | Liquid crystal composition containing nitrogen-containing cyclic compound and liquid crystal display device | JNC CORPORATION (JP) | 2017-06-13 | — | — | US | disclosed |
| US-9676686-B2 | Liquid crystal composition containing nitrogen-containing cyclic compound and liquid crystal display device | JNC CORPORATION (JP) | 2017-06-13 | — | — | US | disclosed |
| US-20160208172-A1 | LIQUID CRYSTAL COMPOSITION CONTAINING NITROGEN-CONTAINING CYCLIC COMPOUND AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2016-07-21 | — | — | US | disclosed |
| US-20160208172-A1 | LIQUID CRYSTAL COMPOSITION CONTAINING NITROGEN-CONTAINING CYCLIC COMPOUND AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2016-07-21 | — | — | US | disclosed |
| US-20100009957-A1 | NOVEL INHIBITORS OF BETA-LACTAMASE | MERCK SHARP & DOHME CORP. | 2010-01-14 | — | — | US | disclosed |
| US-20100009957-A1 | NOVEL INHIBITORS OF BETA-LACTAMASE | MERCK SHARP & DOHME CORP. | 2010-01-14 | — | — | US | disclosed |
| US-20100009957-A1 | NOVEL INHIBITORS OF BETA-LACTAMASE | MERCK SHARP & DOHME CORP. | 2010-01-14 | — | — | US | disclosed |
| EP-2069347-A2 | NOVEL INHIBITORS OF BETA-LACTAMASE | Merck & Co., Inc. (US) | 2009-06-17 | — | — | EP | disclosed |
| WO-2008039420-A2 | NOVEL INHIBITORS OF BETA-LACTAMASE | MERCK & CO., INC. (US) | 2008-04-03 | — | — | WO | disclosed |
| WO-2008039420-A2 | NOVEL INHIBITORS OF BETA-LACTAMASE | MERCK & CO., INC. (US) | 2008-04-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100009957-A1 | NOVEL INHIBITORS OF BETA-LACTAMASE | MGAM, SI, MGAM2 | SMN1; SMN2 3397/4885ALDH1A1 796/4885MAPK1 3643/4885 |
| US-20160208172-A1 | LIQUID CRYSTAL COMPOSITION CONTAINING NITROGEN-CONTAINING CYCLIC COMPOUND AND LIQUID CRYSTAL DISPLAY DEVICE | CCND2, ROCK2, CCND1 | SMN1; SMN2 3119/4885ALDH1A1 3985/4885MAPK1 1098/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.